Method
How to read these pages without treating them like a prescription.
A “protocol” on the internet is usually three different things mixed together. This site keeps them apart.
Three source tiers
| Tier | What it means | How we label it |
|---|---|---|
| Labeled / approved | A regulator-approved product with a package insert (example: tesamorelin 2 mg daily; tirzepatide titration on the Zepbound/Mounjaro label). | Label |
| Human trial | Published clinical trial arms, including investigational drugs such as retatrutide. | Trial |
| Cited research / community range | Doses that appear repeatedly in preclinical papers or research-community references, with little or no adequate human trial behind them. | Cited range |
What a protocol table is — and is not
The tables list amount, route, frequency, and typical duration seen in sources. They are not instructions for self-administration, reconstitution technique, injection sites, or medical treatment. Route is listed because papers specify it; that is not a how-to.
Why ranges exist
Peptides differ in half-life, receptor selectivity, and whether anyone ever ran a proper dose-finding study. Where human PK or a label exists, we prefer that number. Where it does not, we show a range and say so. A wide range is a warning, not a menu.
Side effects
Listed effects are the ones most often reported in trials or consistently mentioned in research summaries. Absence of a long list does not mean safety. Many research peptides have almost no systematic human safety data.